Ancorra Pharma Private Limited

Ancorra Pharma Private Limited - chemicals in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U24290TG2021PTC154209 Incorporated 19 August 2021 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company chemicals MSME · Micro
Revenue · FY 2025
₹14.06 Lakh
▼ 50% YoY
Net loss · FY 2025
₹5.27 Lakh
Net margin -37.5%
EBITDA · FY 2025
-₹5.22 Lakh
EBITDA margin -37.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Ancorra Pharma Private Limited

Data last updated:

Ancorra Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 19 August 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2021PTC154209.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sridhar Boddeti and Koteswara Rao Surisetty.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No – A220 Second Floor Block A Sy. No. 14 20 21& 22 H S Draga Shaikpet, Hyderabad, Telangana, India – 500008.

As per the financials filed for FY 2025, the company reported a revenue of ₹14.06 Lakh, a decline of 50% compared to the previous year. For the same year it recorded a net loss of ₹5.27 Lakh (net margin -37.5%) and EBITDA of -₹5.22 Lakh (EBITDA margin -37.1%).

Ancorra Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0042655).

Company details

CIN U24290TG2021PTC154209
Registration Number 154209
Incorporation Date 19 August 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0042655

Recognitions & Rankings of Ancorra Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-TS-02-0042655

Contact details

Ancorra Pharma Private Limited's registered office is in Hyderabad, Telangana.

  • Registered Address
    Flat No – A220 Second Floor Block A Sy. No. 14 20 21& 22 H S Draga Shaikpet, Hyderabad, Telangana, India – 500008
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Ancorra Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ancorra Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Ancorra Pharma Private Limited, buy the company report.

Financials of Ancorra Pharma Private Limited

FY 2025 filings available

Ancorra Pharma Private Limited reported revenue of ₹14.06 Lakh (down 50% YoY) for FY 2025.

Revenue · FY 2025
₹14.06 Lakh ▼ 50%
Net loss · FY 2025
₹5.27 Lakh margin -37.5%
EBITDA · FY 2025
-₹5.22 Lakh margin -37.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 50%
EBITDA CAGR growth
1 year
▲ 56%
3 years · compounded
▼ 50%

Revenue fell 50% in the latest year. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹5.22 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹5.27 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin-37.1%
Net Profit Margin-37.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ancorra Pharma Private Limited, buy the company report.

Board of directors of Ancorra Pharma Private Limited

Ancorra Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sridhar BoddetiDirector19 Aug 20215 Years 2 MonthsCurrent
Koteswara Rao SurisettyDirector19 Aug 20215 Years 2 MonthsCurrent

Peer comparison

Ancorra Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Asarr Medisol Private Limited₹14.14 Lakh (FY 2018)330.0%New Delhi, Delhi, India
Devraj Medical Centre Private Limited₹14.12 Lakh (FY 2025)6519.0%Uttar Pradesh, India
Gopesh Pharmaceutical Private Limited₹14.09 Lakh (FY 2024)552.0%Jamshedpur, Jharkhand, India
Intervein Laboratories Private Limited₹14.09 Lakh (FY 2025)-84.0%Ahmedabad, Gujarat, India
Lotus Medical Devices India Private Limited₹14.09 Lakh (FY 2025)Yashoda Nagar, Uttar Pradesh, India
Ancorra Pharma Private Limitedthis company₹14.06 Lakh (FY 2025)-₹5.27 Lakh-37.5%-50.0%Hyderabad, Telangana, India
Schrodinger Pharmaceuticals Private Limited₹14.06 Lakh (FY 2024)12.0%Varanasi, Uttar Pradesh, India
Ratika Hospital and Research Centre Private Limited₹14.05 Lakh (FY 2025)-57.0%Mumbai, Maharashtra, India
Nema Holistic Healthcare Private Limited₹14.03 Lakh (FY 2024)57.0%Faridabad, Haryana, India
Brocton Laboratories Private Limited₹14.02 Lakh (FY 2025)-40.0%Ambernath, Maharashtra, India
Veinmd Private Limited₹14.02 Lakh (FY 2025)134.0%Pune, Maharashtra, India

To see the full peer comparison of Ancorra Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ancorra Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Ancorra Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Ancorra Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Koteswara Rao Surisetty was appointed as Director on 19 Aug 2021.

AGM
Ancorra Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ancorra Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Koteswara Rao Surisetty was appointed as Director.
Appointed
Sridhar Boddeti was appointed as Director.
Incorporation
19 Aug 2021
Ancorra Pharma Private Limited was registered on 19 Aug 2021 with Roc Hyderabad & aged 5 years 3 months as per MCA records.

Frequently asked questions

Ancorra Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 19 August 2021 (5+ years old) and is registered under CIN U24290TG2021PTC154209.

Ancorra Pharma has 2 current directors:

The latest financial statements of Ancorra Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Ancorra Pharma is U24290TG2021PTC154209. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ancorra Pharma was incorporated on 19 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Ancorra Pharma by revenue are Asarr Medisol Private Limited, Devraj Medical Centre Private Limited, Gopesh Pharmaceutical Private Limited, Intervein Laboratories Private Limited, Lotus Medical Devices India Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).

Koteswara Rao Surisetty was appointed as Director on 19 Aug 2021. Sridhar Boddeti was appointed as Director on 19 Aug 2021.

Yes, Ancorra Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0042655).

The registered office of Ancorra Pharma is at Flat No – A220 Second Floor Block A Sy. No. 14 20 21& 22 H S Draga Shaikpet, Hyderabad, Telangana, India – 500008.

Ancorra Pharma operates in the chemicals industry, in the manufacturing segment.

Ancorra Pharma can be reached at its registered office: Flat No – A220 Second Floor Block A Sy. No. 14 20 21& 22 H S Draga Shaikpet, Hyderabad, Telangana, India – 500008.